ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016 YONKERS, NY--(Marketwired - May 03, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and...

ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference YONKERS, NY--(Marketwired - March 29, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and...